Ownership history in XTX Topco Ltd · 6 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in INMUNE BIO INC (INMB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 68,865 | +20,121 | +41.3% | 0.00% | $107K | $1.56 |
| 2025 Q3 | REDUCED | 48,744 | -77,103 | -61.3% | 0.01% | $101K | $2.07 |
| 2025 Q2 | ADDED | 125,847 | +88,928 | +240.9% | 0.01% | $291K | $2.31 |
| 2025 Q1 | REDUCED | 36,919 | -24,352 | -39.7% | 0.01% | $288K | $7.81 |
| 2024 Q4 | ADDED | 61,271 | +15,018 | +32.5% | 0.02% | $286K | $4.67 |
| 2024 Q3 | INITIATED | 46,253 | — | — | 0.02% | $249K | $5.39 |
As of 2025 Q4 — sorted by position size